🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Registration and Abstract submission are open! We are thrilled to inform that the registration and abstract submission for our 2025 meeting are now open! Share your work with the iNKT community and join us for this pivotal event in Prague. meeting2025.cirt-net.org #iNKT #CiRT

Submit Your iNKT Abstract Today: meeting2025.cirt-net.org And join the iNKT community for our inaugural meeting in Prague, February 2025. This is a unique opportunity to share your research with international iNKT experts. We look forward to seeing you! #iNKT

The #iNKT community is gearing up for its highly anticipated first iNKT meeting! Join us this February in Prague for a deep dive into the last iNKT advancements. Check out our program at meeting2025.cirt-net.org. Haven’t registered? Late registration is availible. See you there!

#CiRT community is ready for the first-ever iNKT meeting! We are so excited to see so many friends from across the globe! Stay tuned for live updates.  #iNKT #CellTherapy

So excited for the 1st meeting of @CiRT_iNKT Consortium for #iNKT Research & Therapy in beautiful Prague! Honored to share our work w/ others who love #iNKTcells too & work together to bring iNKTcells #celltherapy for cancer & #GVHD. WashU Medicine Pediatrics WashU Medicine Division of Oncology WUSTL Immunology

Registration to the iNKT meeting is open! Phenomenal presenters are ready to share their work, with a great attendance!

It's happening! The iNKT meeting has started! Inspiring and visionary opening from our co-funders, Monika Holubova and Antonia Rotolo. Monika Holubová Antonella

Fantastic opening with Dr. Giulia Casorati's talk on harnessing the iNKT cell platform for iNKT immunotherapy for cancer.

Wow! Dr. Melissa Mavers has just provided a very insightful overview of diversity in human iNKT cells across immunologically relevant hematologic tissues Melissa Mavers

Beautiful presentation from our Scientific Advisor Dr. Dominik Schneidawind showing how CAR iNKTs represent the best of both CAR and iNKT worlds

Inspiring update from Dr. Jenny Gumperz and how iNKT can improve outcomes of hematopoietic transplantation

We are so excited to have Dr. Leonid Metelitsa here and learn from him about how to best leverage iNKT biology and CAR designs. And to learn his clinical experience with CAR-iNKTs successfully administered in one of the first clinical trials.

One of the fathers of iNKT clinical applications, Dr. Mark Exley, has just finished his phenomenal talk on getting iNKT cells back to patients!

Dr. Lili Yang, pioneering IPSCs derived iNKT cells, has captivated all of us with her vision on off-the-shelf iNKT therapies

We have just heard from Dr. Iris Marchal, Nature Biotechnology associate editor, about tips and opportunities to broaden the reach of our iNKT work. Wonderful! Iris Marchal Nature Biotechnology

Day 1 is in the books. It was amazing and we continue tomorrow, thank you iNKT community. #CiRT #iNKT

It´s day 2!!! Dr. Marie-Thérèse Rubio continues to enrich our meeting with great insights on how to learn from our transplant patients to make our iNKT research more impactful for clinical use.

Dr. Anastasios Karadimitris summarized the evidence (strongly) supporting clinical applications of iNKT cell-based therapeutics in patients

And that´s a wrap! Co-Funder Dr. Lucie Houdova recapitulated the meeting and elaborated on the future directions of #CiRT. We also heard from other cofounders and best poster and short talk were awarded. Thanks to everyone. Monika Holubová Antonella

Our study on human #iNKT cell diversity across hematologic tissues-now out in Cell Reports! #iNKTcells are important in immunity & potential #CellTherapy for cancer & #GVHD-learning more of their biology is👍. Kudos to Reyka Jayasinghe, PhD and all coauthors.🧵 sciencedirect.com/science/articl…